Guardant Health AMEA

  • Home
  • Guardant Health AMEA

Guardant Health AMEA Precision Oncology | Liquid Biopsy

We were pleased to join the recent Taiwan conference on The Clinical Application of Liquid Biopsy in Solid Tumors: Now a...
29/10/2025

We were pleased to join the recent Taiwan conference on The Clinical Application of Liquid Biopsy in Solid Tumors: Now and Future. The conference was hosted by the Taiwan Society of Personalized Medicine, and co-organized by the Taiwan Oncology Society, Taiwan Precision Medicine Society and Taiwan Society of Laboratory Medicine.

Conference participants called for the inclusion of liquid biopsy in Taiwan’s National Health Insurance (NHI) to ensure that cancer patients have faster access to the most appropriate treatment. Karthik GM, Director, Regulatory Affairs, Guardant Health AMEA and Chung-Fan Lee, Head of Commercial for Taiwan, highlighted the importance of liquid biopsies in treatment selection for patients who do not qualify for tissue biopsies. They also spoke about the growing worldwide acceptance and approval of liquid biopsies as standard of care.

The push for NHI inclusion of liquid biopsy testing and matched therapies is gaining momentum among Taiwanese physicians and key opinion leaders. Guardant Health welcomes these developments and remains committed to expanding access to fast, accurate, and comprehensive blood-based genomic profiling for cancer patients in Taiwan.



Read more about the conference: https://news.gbimonthly.com/tw/article/show.php?num=80907&range=news

Behind every cancer treatment decision is timely, precise insight. As treatment options expand, understanding the full g...
24/10/2025

Behind every cancer treatment decision is timely, precise insight. As treatment options expand, understanding the full genomic landscape of advanced breast cancer is key to making informed decisions.

In our continuing Hear from the Expert series this Breast Cancer Awareness month, hear from Dr. Shaheenah Dawood about the role of comprehensive genomic profiling in advanced breast cancer.

At Guardant Health, our robust real-world data platform GuardantINFORM has enabled us to uncover meaningful insights tha...
21/10/2025

At Guardant Health, our robust real-world data platform GuardantINFORM has enabled us to uncover meaningful insights that push the boundaries of precision medicine.

We are proud to announce our collaboration with Taiho Pharmaceutical to discover new biomarker signatures to address unmet needs in early-stage cancer patients at high risk of recurrence, and accelerate development of relevant therapies.

We welcome more pharma partners to join us in harnessing data-driven innovation to shape the future of precision oncology.

Link to press release: https://www.taiho.co.jp/en/release/2025/20250924.html

Happy Diwali from all of us at Guardant Health!May the light of Diwali shine as brightly as the hope we share in every s...
17/10/2025

Happy Diwali from all of us at Guardant Health!

May the light of Diwali shine as brightly as the hope we share in every step towards better health.

Every patient’s journey with breast cancer is unique – and every story helps us understand how to care better.In our con...
16/10/2025

Every patient’s journey with breast cancer is unique – and every story helps us understand how to care better.

In our continuing Hear from the Expert series, Dr. Herdee Luna shares how advances such as comprehensive genomic profiling helps doctors to choose more personalized treatments for each patient.

Because awareness isn’t just about early detection – it’s also about knowing that care can be as individual as you are.

We are looking forward to be part of the upcoming ESMO - European Society for Medical Oncology Eight independent clinici...
13/10/2025

We are looking forward to be part of the upcoming ESMO - European Society for Medical Oncology

Eight independent clinicians will share results from research collaborations with Guardant Health AMEA, and new real-world data across solid tumor types - reinforcing the importance of evidence that reflects everyday patient care.

A heartfelt thank you to the researchers and collaborators Jia (Jenny) Liu, Nitesh Rohatgi, Nir Peled, A. Rauthan, S***a Fukuoka, Shin Kobayashi, Hiroki Osumi, and Seiichiro Mitani. We remain committed to collaborating with clinicians to advance real-world evidence in precision oncology, and improving outcomes for patients everywhere.

This Breast Cancer Awareness Month, we invite oncologists and healthcare professionals to join our upcoming webinar on C...
10/10/2025

This Breast Cancer Awareness Month, we invite oncologists and healthcare professionals to join our upcoming webinar on Clinical Utility of Comprehensive Genomic Profiling (CGP) in Advanced Breast Cancer Management.

📅When: October 15, 2025
⏰ Time: 9:30 PM – 11:00 PM (GMT +8)

Hear from leading clinical experts as they discuss clinical applications, real-world cases, and how CGP continues to shape personalized cancer care in advanced breast cancer.

Register here: https://guardanthealth.zoom.us/webinar/register/1017600725006/WN_9TQJqYA1S3G2y9EZ3mtxOQ

It was an honor to be part of Best of ASCO Philippines 2025, where Dr. Arthur Lui presented on the role of comprehensive...
08/10/2025

It was an honor to be part of Best of ASCO Philippines 2025, where Dr. Arthur Lui presented on the role of comprehensive genomic profiling (CGP) in colorectal cancer. Dr. Lui highlighted the genomic heterogeneity of colorectal cancer, and emphasized the value of broad testing due to actionable biomarkers and emerging biomarkers.

“The integration of both tissue and liquid CGP into routine colorectal cancer care establishes a framework for precision oncology—informing first-line strategies, identifying resistance in later lines, and guiding rechallenge or novel targeted therapies in heavily pretreated patients.” shared Dr. Lui.

Real-world evidence shows improved survival with CGP-guided therapy, reinforcing its essential role in colorectal cancer care. At Guardant Health AMEA, we remain committed to driving innovation and, together with the oncology community, shaping a future of better outcomes for patients.

This Breast Cancer Awareness Month, our Hear from the Expert series will share perspectives of leading oncologists on th...
06/10/2025

This Breast Cancer Awareness Month, our Hear from the Expert series will share perspectives of leading oncologists on the role of precision oncology in advancing breast cancer care.

Join us this October as we spotlight their voices and our shared mission to achieve progress in breast cancer care.

We invite oncologists and healthcare professionals to join our upcoming webinar on Multiomics in Precision Oncology.📅Whe...
03/10/2025

We invite oncologists and healthcare professionals to join our upcoming webinar on Multiomics in Precision Oncology.

📅When: October 8, 2025
⏰ Time: 9:00–10:30 PM (GMT+8)

Discover how multiomic approaches with a tissue test delivers deeper clinical insights to support decision-making, even when working with limited biopsy samples in advanced solid tumors. Hear directly from leading clinicians as they share perspectives and case discussions on using multiomics to support informed treatment decisions.

Register here: https://guardanthealth.zoom.us/webinar/register/WN_9GWRSrzbSbyrb4D5KGWeSQ #/registration

We were pleased to join IIC (InsurInnovator Connect) Asia 2025, where our Commercial VP Divya Mehta joined a panel discu...
30/09/2025

We were pleased to join IIC (InsurInnovator Connect) Asia 2025, where our Commercial VP Divya Mehta joined a panel discussion on the future of life and health insurance.

A clear message emerged: insurers are envisioning a role beyond critical illness payouts - they want to partner with policyholders on their health and wellness journey, not just when illness strikes.

As Divya Mehta shared: “We need to incentivize and empower people to manage their health. The real opportunity is how we, as an ecosystem – insurers, healthcare providers, pharma and medical device companies – can collaborate to make this possible.”

At Guardant Health AMEA, we believe this collaborative approach can build a stronger, more resilient ecosystem – one that helps people live healthier lives and ensures insurers can deliver even greater value to their members.

Our CEO, Simranjit Singh, represented Guardant Health AMEA at the 15th APEC High Level Meeting on Health and the Economy...
22/09/2025

Our CEO, Simranjit Singh, represented Guardant Health AMEA at the 15th APEC High Level Meeting on Health and the Economy (HLMHE15), which was chaired by H.E. Dr. Jeong Eun Kyeong, Minister of Health and Welfare of the Republic of Korea. >21 member economies came together, and the Health Ministers issued a Joint Ministerial Statement to reaffirm the importance of integrated approaches to cancer prevention, screening, diagnostics and palliative care.

We applaud the collective efforts by APEC - Asia-Pacific Economic Cooperation and member economies in strengthening cancer control, and their commitment to mobilizing resources. Guardant Health AMEA looks forward to partnering with governments and health systems, to advance cancer control and improve outcomes.

📄: HLMHE15 Health Ministers Joint Ministerial Statement: https://www.apec.org/meeting-papers/sectoral-ministerial-meetings/health/2025-apec-high-level-meeting-on-health-and-the-economy

Address

21 Biopolis Road, # 03-28, Nucleos, Singapore 138567

138567

Opening Hours

Monday 09:00 - 17:00
Saturday 00:00 - 00:15

Alerts

Be the first to know and let us send you an email when Guardant Health AMEA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Guardant Health AMEA:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram